Skip to content

Investigating the immune function after functional cure of HBV

Investigating the immune function after functional cure of HBV - SLOSS IMMUNE FUNCTION

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58001
Enrollment
20
Registered
2025-04-29
Start date
2025-12-29
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HBV

Interventions

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: No signs of relevant disease • Previous chronic HBV infection (6 months or more HBsAg+ in the last 10 years) • Undetectable HBsAg levels • Undetectable HBV DNA levels • Ability to provide written informed consent

Exclusion criteria

Exclusion criteria: • Females who are pregnant or breast-feeding. • Participants with an insurmountable language barrier due to which it is impossible to perform correct and complete information. • An organic brain syndrome or other significant psychiatric abnormality which would compromise the ability to give informed consent. • History or other evidence of severe illness, malignancy or any other condition which would make the participant, in the opinion of the investigators, unsuitable for the study.

Design outcomes

Primary

MeasureTime frame
Phenotyping B and T cells of individuals who have achieved HBV functional cure using flow cytometry.

Secondary

MeasureTime frame
Determine RNA expression profiles of HBV specific B and T cells from individuals who have recovered from chronic HBV infections.

Countries

Netherlands

Contacts

Public ContactW Hamerslag-de Groot

Erasmus MC, Universitair Medisch Centrum Rotterdam

crb@erasmusmc.nl010-7033036

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026